Effects of 8 years of treatment with tibolone 2.5 mg daily on postmenopausal bone loss

Osteoporosis International

Volumn 12, Issue 6, 2001, Pages 478-483

  Rymer, J ^a   Robinson, J ^a   Fogelman, I ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bone loss; Fracture; Hormone replacement therapy; Tibolone

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CALCIUM; CREATINE; TIBOLONE;

ADULT; ARTICLE; BONE ATROPHY; BONE MINERAL; CALCIUM METABOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; FEMUR; HIRSUTISM; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; OSSIFICATION; POSTMENOPAUSE; PRIORITY JOURNAL; SPINE; TREATMENT OUTCOME; VAGINA BLEEDING; VAGINITIS; VERTIGO;

ALKALINE PHOSPHATASE; ANABOLIC AGENTS; BONE DENSITY; CALCIUM; CREATININE; DENSITOMETRY, X-RAY; FEMALE; FEMUR NECK; HORMONE REPLACEMENT THERAPY; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; NORPREGNENES; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PROSPECTIVE STUDIES;

EID: 0034954180     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980170093     Document Type: Article

References (21)

1. Estrogen replacement therapy. I. A 10-year prospective study in the relationship to osteoporosis
2. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women
3. Compliance considerations with hormone replacement therapy
4. Compliance considerations with oestrogen replacement: Withdrawal bleeding and other factors
5. Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users
6. In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD-14) and its metabolites on human endometrium
7. Long-term effects of tibolone on the genital tract in postmenopausal women
8. A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms
9. Tibolone exerts an estrogenic effect on bone leading to prevention of bone loss and reduction in bone resorption in ovariectomized rats
10. Effect of tibolone on postmenopausal bone loss
11. Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: A two-year randomized, placebo-controlled study
12. Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women
13. The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women
14. A randomized study of tibolone on bone mineral density in osteoporotic postmenopausal women with previous fractures
15. Bone density at various sites for prediction of hip fractures
16. Prediction of fracture risk using axial bone mineral density in a perimenopausal population: A prospective study
17. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: Recognition of a major effect
18. Cigarette smoking, alcohol and caffeine consumption, and bone mineral density in postmenopausal women
19. Effects of progestagens and Org OD14 in in vitro and in vivo tumor models
20. Compliance with hormone replacement therapy (HRT) after screening for post-menopausal osteoporosis
21. Effect of 10 years' hormone replacement therapy on bone mineral content in post-menopausal women